ICML 2019 | Road ahead for immunotherapy in Hodgkin lymphoma: bispecifics & CAR-T

Stephen Ansell

Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN, discusses the road ahead for immunotherapy in Hodgkin lymphoma, touching upon bispecifics and CAR T-cells. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video  
Similar topics